https://orcid.org/0000-0003-3989-944X
Current Duke Appointments & Affiliations
Associate Professor of Neurology
·
2023 - Present
Neurology, MS & Neuroimmunology,
Neurology
Residency Program Director in the Department of Neurology
·
2023 - Present
Neurology,
Clinical Science Departments
Recent Scholarly Works
Corrigendum to "Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: presentation and outcomes of adults at a single center" [J. Neuroimmunol. 2022, Article 577987].
Journal article J Neuroimmunol · September 6, 2026 Full text Link to item CiteRe-challenge of immune checkpoint inhibitor after ICI-encephalitis: A case report.
Journal article J Neuroimmunol · August 2026 Immune-checkpoint inhibitor (ICI) related encephalitis (ICI-IE) is a severe adverse event, associated with high morbidity and mortality and requiring prompt ICI discontinuation. The safety of rechallenge with ICI after initial adverse event is largely unkn ... Full text Link to item CiteThe Interplay of Parental Leave, Career Achievement, and Burnout in Academic Neurologists: A Multicenter Study.
Journal article J Womens Health (Larchmt) · July 1, 2026 BACKGROUND: Despite the health benefits of parental leave (PL), many physicians in the United States take little to no PL. This issue is particularly pressing in academic neurology, which faces high burnout rates and a projected shortage. This study evalua ... Full text Link to item CiteRecent Grants
A Phase 1/2a, Open-Label, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX319 in Subjects with Primary or Secondary Progressive Multiple Sclerosis
Clinical TrialPrincipal Investigator · Awarded by Tr1X, Inc. · 2026 - 2042BEAT-MS
Clinical TrialPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2020 - 2028A phase IV, prospective, multicenter, open-label, mothermilk study to evaluate ofatumumab concentration in the breast milk of lactating women with relapsing forms of multiple sclerosis receiving ofatumumab (Kesimpta ®
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2024 - 2027View All Grants
Education
State University of New York Upstate Medical University ·
2013
M.D.